• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

gilead sciences

  1. FIRE THE MEDICAL AFFAIRS VPs ALREADY! CORRUPT!!!!!!! THEY ARE IDIOTS!!!!!!!!!!!!!!!!!!!

    They have lost credibility with the organization and deserve to be fired. File complaints and make known in surveys!
    • anonymous
    • Thread
    • gilead sciences medical affairs
    • Replies: 6
    • Forum: Gilead Sciences

  2. ViiV Rep Fired-Why Wasn’t His Boss?

    ViiV Rukobia rep got fired for breaking every pharma rule. He was compliance nightmare. His boss knew and said and did nothing because rep’s #s were good. Boss lied to save his ass, bullshit move. Fact they didn’t fire boss is horse shit with everything this guy does. Rep AND boss both should...
    • anonymous
    • Thread
    • gilead gilead sciences glaxosmithkline gsk hiv viiv
    • Replies: 31
    • Forum: GlaxoSmithKline

  3. ViiV rep breaking all the rules! Gilead knows!

    When did ViiV reps start gifting docs vegetables? Bringing non GSK-ViiV pharmacist on calls and lunches? ViiV so hard up they’ll break pharma rules? A lot of bad stuff goes on in Florida but vegetables lmao!!! Dude, Gilead reporting you and your boss. Offices talk pal.
    • anonymous
    • Thread
    • gilead gilead sciences glaxosmithkline gsk viiv
    • Replies: 55
    • Forum: GlaxoSmithKline

  4. Gilead CA and TX.

    Dude. Gilead kicking Abbvie ass in HCV in CA now. And I hear they have it locked up for 2021. Good night Abbvie. Sleep tight. Also Gilead has it locked up in TX. Good night. Sleep tight.
    • anonymous
    • Thread
    • gilead sciences
    • Replies: 3
    • Forum: AbbVie

  5. New Hire

    Hi I am wondering what new hire package is like? How much relo do you get and also how much new hire equity do you get ...I know may be different dependent on grade level. Also is sign on bonus too much to ask for?
    • anonymous
    • Thread
    • gilead sciences new hire
    • Replies: 2
    • Forum: Kite Pharma

  6. Novo Nordisk reports first quarter results

    Novo Nordisk says pricing pressure within diabetes to continue, especially in the US. First quarter 2019 results: Sales from North America Operations declined 4% on constant exchange rates.
    • anonymous
    • Thread
    • biopharma diabetes gilead sciences insulin merck novo nordisk obesity pfizer pharmaceutical sanofi
    • Replies: 3
    • Forum: Novo Nordisk

  7. NASH

    Nonalcoholic steatohepatitis (NASH) liver fibrosis is the new golden goose in the biotech space. More than 40 companies are taking part in clinical trials to bring the first NASH drug to market. Very few of them are close to seeing some success. NASH’s market value is set to increase to $21.5...

  8. Gilead failed, but Intercept succeeded

    Last week, Gilead failed in Phase 3 clinical trial for NASH drug. Today, Intercept has become the first player in the NASH area to complete a pivotal Phase 3 study in patients with liver fibrosis.
    • anonymous
    • Thread
    • clinical trials drug europe fda gilead gilead sciences intercept pharmaceuticals liver fibrosis nash viking therapeutics
    • Replies: 1
    • Forum: Gilead Sciences
Top Bottom
Back